Artiva Biotherapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$4.03

+0.16 (+4.13%)

As of Feb 8, 2:12 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 11 92%

Hold 1 8%

Sell 0 0%

Price Target

Analyst Price Target +102.0% upside

Low Target $7.28

Average Target $8.14

High Target $10.62

Current Price $4.03

Current
$4.03

Target
$8.14

$7.28 $8.14 avg $10.62

Scenario Analysis

Bear Case

$7.28

80.6%

Low target

Base Case

$8.14

+102.0%

Avg target

Bull Case

$10.62

+163.5%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$8.16

-50.6% from high

52-Week Low

$6.24

+-35.4% from low

Target vs 52W High

$8.14

-0.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%